| Ovariectomized rats’ femur treated with fibrates and statins. Assessment of pore-size distribution by 1H-NMR relaxometry | In-vitro | Şipoş, R.S., Fechete, R., Chelcea, R.I., Moldovan, D., Pap, Z., Pávai, Z., Demco, D.E. | 2015 | Romania | Fenofibrate | Neutral |
| The PPAR agonist fenofibrate improves the musculoskeletal effects of exercise in ovariectomized rats | In vitro | Mosti, M.P., Ericsson, M., Erben, R.G., Schüler, C., Syversen, U., Stunes, A.K. | 2016 | Norway | Fenofibrate | Positive |
| Fenofibrate decreases the bone quality by down regulating Runx2 in high-fat-diet induced Type 2 diabetes mellitus mouse model | In vitro | Shi, T., Lu, K., Shen, S., Tang, Q., Zhang, K., Zhu, X., Shi, Y., Liu, X., Teng, H., Li, C., Xue, B., Jiang, Q. | 2017 | China | Fenofibrate | Negative |
| Fenofibrate induces PPARα and BMP2 expression to stimulate osteoblast differentiation | In vitro | Kim, Y.H., Jang, W.G., Oh, S.H., Kim, J.W., Lee, M.N., Song, J.H., Yang, J.W., Zang, Y., Koh, J.T. | 2019 | Republic of Korea | Fenofibrate | Positive |